Stay updated on Vibecotamab in MRD+ AML/MDS Clinical Trial
Sign up to get notified when there's something new on the Vibecotamab in MRD+ AML/MDS Clinical Trial page.

Latest updates to the Vibecotamab in MRD+ AML/MDS Clinical Trial page
- Check3 days agoChange DetectedNew 2025-10-27 update adds the Study Status entry to the record history; the total versions now show 16, and an older entry from 2025-06-03 was removed.SummaryDifference0.4%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference12%

- Check32 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.3%

- Check46 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed. No other core content, pricing, or availability changes were detected.SummaryDifference0.7%

- Check53 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.7%

- Check60 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific location terms and listed countries.SummaryDifference16%

Stay in the know with updates to Vibecotamab in MRD+ AML/MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vibecotamab in MRD+ AML/MDS Clinical Trial page.